Ochsner Health, the 41-hospital system serving Louisiana, Mississippi and the Gulf South, is joining the ranks of academic medical institutions committed to paying the tuition of homegrown future physicians.
DSP-1181, a pharmaceutical drug created by AI technology, has entered phase 1 clinical trials in Japan. This is the first time an AI-made drug has reached this point in the development process.
AI models can be trained to predict outcomes in meningioma patients, according to new research published in npjDigital Medicine. The study’s authors even developed a free smartphone app so others can explore their work.
AI promises to make a titanic impact on radiology, but most of the attention tends to focus on its ability to identify important findings in medical images. What about the technology’s non-interpretive qualities?
Citing data previously published from the National Health Interview Survey, authors Amy Cha, PhD, MPH, and Robin Cohen, PhD, point out that major medical bills piling up for one member of a family tend to weaken the entire household.
In the near future, patients may have their blood drawn and tested by an advanced robot—and it’s a move that would benefit both patients and healthcare providers.
The WHO says its current strategic-response objectives begin with limiting human-to-human transmission—including reducing contact between possible Covid-19 patients and healthcare workers—and preventing further international spread from China.